Table 2.
Characteristic of patients demographic
| Variables | No of patients available | Median (range) | N (%) |
|---|---|---|---|
| Age (years) | 15 | 11.1 (0.6–17) | |
| Race | 8 | ||
| Caucasian | 2 (25%) | ||
| African American | 6 (75%) | ||
| Sex | 9 | ||
| Male | 2 (22.2%) | ||
| Female | 7 (77.8%) | ||
| BMI | 6 | 22.8 (11.2–31) | |
| Comorbid diseases | 5 | ||
| Edwards syndrome | 1 (20%) | ||
| Diabetes | 1 (20%) | ||
| Hypertension | 1 (20%) | ||
| Obese | 2 (40%) | ||
| First symptom onset (days) | 8 | 10 (2-27) | |
| Postmortem COVID-19 testing | |||
| Antibody | 1 | ||
| Positive | 1 (100%) | ||
| Nasopharyngeal PCR | 9 | ||
| Positive | 7 (77.8%) | ||
| Lab parameters | Reference range | ||
| Hemoglobin, g/dL | 7 | 10.6 (8.8–12.2) | 10–15.5 |
| Hematocrit, % | 7 | 31.7 (28.8–39.6) | 32–44 |
| Platelets, ×103 cells per μL | 7 | 252.3 (111–296) | 150–400 |
| White blood cell count, ×103 cells per mm3 | 7 | 19 (9.3–32.6) | 5–10 |
| Lymphocytes, % | 7 | 11.5 (0.79–58) | 20–40 |
| Absolute neutrophil count (K/mm3) | 6 | 62.8 (28–95) | 55–70 |
| Urea, mg/dL | 6 | 61.3 (23–122) | 5–18 |
| Creatinine, mg/dL | 6 | 0.9 (0.26–1.87) | 0.5–1.0 |
| D-dimer, ng/mL | 6 | 2532.4 (11.5–2324) | <250 |
| Troponin T, ng/mL | 6 | 0.1 (0.002–0.3) | <0.1 |
| Creatine kinase myocardial band, ng/mL | 5 | 5.76 (0.64–30.7) | 0.1–2.88 |
| Creatine kinase, U/L | 5 | 96 (50–1008) | <167 |
| Fibrinogen, mg/dL | 5 | 356 (111–513) | 200–393 |
| aPTT, s | 4 | 39.05 (36–57.9) | 25.4–38.9 |
| Ferritin, ng/mL | 4 | 707 (159–1501) | 20–200 |
| Triglycerides, mg/dL | 5 | 183.5 (59–272) | 100–129 |
| Interleukin-6, pg/mL | 1 | 4105 | 0.2–7.8 |
| Blood pH | 1 | 7.2 | 7.35–7.45 |
| Bicarbonate, mEq/L | 1 | 15.7 | 21·0–28·0 |
| PaCO2, mm Hg | 1 | 41 | 35–45 |
| PaO2, mm Hg | 1 | 60 | 80–90 |
| ScvO2, % | 1 | 87.2 | 60–85 |
| Lactate, mg/dL | 6 | 28 (14–39) | 4.5–14.4 |
| C-reactive protein, mg/L | 7 | 134.1 (1.5–266.6) | <10 |
| Erythrocyte sedimentation rate (mm/h) | 1 | 74 | <10 |
| Total protein, g/dL | 2 | 6.1 (5–7.2) | 6–8 |
| Albumin, g/dL | 7 | 3 (2.5–4.3) | 3.8–5.4 |
| Total bilirubin, mg/dL | 6 | 3.04 (0.3–11.1) | 0.3–1 |
| Direct bilirubin, mg/dL | 5 | 0.37 (0.23–9.84) | <0.2 |
| Aspartate aminotransferase, U/L | 7 | 155.9 (20–506) | 10–50 |
| Alanine aminotransferase, U/L | 7 | 142.1 (13–376) | 4–36 |
| Gamma-glutamyl transferase, U/L | 6 | 217.5 (9–479) | 5–27 |